Sino Biopharmaceutical Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sino Biopharmaceutical Limited with three other
companies in this sector in Hong Kong:
CSPC Pharmaceutical Group Ltd
sales of 12.37 billion Hong Kong Dollars [US$1.58 billion]
of which 72%
was Finished Drugs),
China Traditional Chinese Medicine Holdings Co Ltd
(7.62 billion Hong Kong Dollars [US$976.55 million]
of which 67%
was Concentrated TCM Granules), and
The United Laboratories International Holdings Limited
(7.06 billion Hong Kong Dollars [US$905.00 million]
of which 41%
was Bulk Medicine).
During the year ended December of 2016, sales at
Sino Biopharmaceutical Limited were HK$15.83 billion (US$2.03 billion).
increase of 8.8%
versus 2015, when the company's sales were HK$14.55 billion.
This was the fifth consecutive year of sales increases at Sino Biopharmaceutical Limited
(and since 2011, sales have increased a total of 174%).
Sales of Modernized Chinese Medicines and Chemica saw an increase
8.9% in 2016, from
HK$14.05 billion to HK$15.30 billion.